Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials

被引:0
|
作者
Laukhtina, E. [1 ]
Mori, K. [2 ]
Mostafaei, H. [2 ]
Merseburger, A. S. [3 ]
Nyirady, P. [4 ]
Moschini, M. [5 ]
Quhal, F. [2 ]
Pradere, B. [2 ]
Sari, Motlagh R. [2 ]
Schuettfort, V. M. [2 ]
Enikeev, D. [1 ]
Shariat, S. F. [2 ]
机构
[1] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Hosp Schleswig Holstein, Dept Urol, Lubeck, Germany
[4] Semmelweis Univ, Dept Urol, Budapest, Hungary
[5] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
P0834
引用
收藏
页码:S1164 / S1165
页数:2
相关论文
共 50 条
  • [31] Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
    Gresham, Gillian K.
    Wells, George A.
    Gill, Sharlene
    Cameron, Christopher
    Jonker, Derek J.
    BMC CANCER, 2014, 14
  • [32] Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials
    Dawit Getachew Assefa
    Ahmed Bedru
    Eden Dagnachew Zeleke
    Solomon Emiru Negash
    Dejene Tolossa Debela
    Wondowsen Molla
    Nebiyu Mengistu
    Tigist Tekle Woldesenbet
    Neway Fekede Bedane
    Violet Dismas Kajogoo
    Mary Gorret Atim
    Tsegahun Manyazewal
    Archives of Public Health, 81
  • [33] Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: A systematic review and network meta-analysis of randomized controlled trials
    Assefa, Dawit Getachew G.
    Zeleke, Eden Dagnachew
    Manyazewal, Tsegahun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 565 - 565
  • [34] Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials
    Assefa, Dawit Getachew
    Bedru, Ahmed
    Zeleke, Eden Dagnachew
    Negash, Solomon Emiru
    Debela, Dejene Tolossa
    Molla, Wondowsen
    Mengistu, Nebiyu
    Woldesenbet, Tigist Tekle
    Bedane, Neway Fekede
    Kajogoo, Violet Dismas
    Atim, Mary Gorret
    Manyazewal, Tsegahun
    ARCHIVES OF PUBLIC HEALTH, 2023, 81 (01)
  • [35] Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis
    Liu, Gui-Feng
    Li, Gui-Jie
    Zhao, Hang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) : 511 - 523
  • [36] Effect of subsequent chemotherapy on overall survival in first-line chemotherapy with targeted agents for patients with metastatic colorectal cancer: Systematic review and meta-analysis of randomized control trials.
    Sakai, Daisuke
    Kudo, Toshihiro
    Kato, Aya
    Sueda, Toshinori
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
    Shin, Sooyoung
    Noh, Yoojin
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 833 - 847
  • [38] Topotecan plus carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer: a meta-analysis of randomized controlled trials
    Zhang, Hui
    Jia, Lin
    Xu, Yintao
    Zhou, Xun Clare
    Kong, Beihua
    Li, Dadong
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (02) : 67 - 73
  • [39] First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
    Hahn, Andrew W.
    Klaassen, Zachary
    Agarwal, Neeraj
    Haaland, Benjamin
    Esther, John
    Ye, Xiang Y.
    Wang, Xuechen
    Pal, Sumanta K.
    Wallis, Christopher J. D.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (06): : 708 - 715
  • [40] Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
    Xu, Shan
    Sak, Ali
    Erol, Yasin Bahadir
    CANCER CONTROL, 2021, 28